REPH
Recro Pharma, Inc.
Possible Member of 10% Group, 10% James E Flynn sold $444K of Recro Pharma, Inc.
Sold$444,010
$7.06Price
62,868Shares
−3%Stake
What REPH did after the filing
Prices for REPH after this filing aren't in yet.
Traded Wed, Jun 7. Filed Fri, Jun 9, 4:07 PM ET, after the close. Not investment advice.